Antithyroid Drug Therapy And Cardiovascular Morbidity

Antithyroid Drug Therapy And Cardiovascular Morbidity Overview The impact of thyroid function test (TFT) variability and its link to adverse health outcomes in antithyroid drug (ATD) therapy remains an unexplored area. This study aimed to investigate the relationship between TFT variability and cardiovascular morbidity during ATD therapy. Conducted at Tampere University Hospital,

Levothyroxine Therapy and Depression

Levothyroxine Therapy and Depression Subclinical hypothyroidism is a condition defined as elevated thyroid-stimulating hormone (TSH) levels in combination with free thyroxine levels within the reference range. It is an early form of hypothyroidism, a condition in which the body doesn't produce enough thyroid hormones. The term “subclinical” refers to the serum

Antithyroid Drug Therapy And Cardiovascular Morbidity